- January 2023Greta Wiessner: Making the Civil Rights Movement a Modern-Day Reality
- December 30, 2022Astellas US LLC v. Hospira, Inc.
- Takeda Pharm. Co. Ltd. v. Norwich Pharms., Inc.
- December 2022Voluntary Cessation Doctrine in Trademark Cases
- Genentech, Inc. v. Sandoz Inc.
- December 21, 2022Arius Two, Inc. v. Alvogen PB Rsch. & Dev. LLC
- December 2022The Note From the Deliberating Jury
- December 2022Chambers v. Gold Medal Bakery: An Illustration of Privilege in Shareholder Suits
- December 2022Wearing the Right Hat
- Vanda Pharms., Inc. v. Teva Pharms. USA, Inc.
- Ferring Pharms. Inc. v. Fresenius Kabi USA, LLC
- December 8, 2022Lessons From MMAS Research About Dispositive Pitfalls in Copyright Litigation
- December 7, 2022Briefly: Electing Justice: How to Judge Judges
- December 2, 2022Tribal Jurisdiction Under the Second Montana Exception: Implications of United States v. Cooley
- Bausch Health Ireland Ltd. v. Padagis Israel Pharms. Ltd.,
- SCOTUS Term in Review
- 5 Principles For Better Professional Development Programs
- How to Use the USPTO Patent Public Search Tool
- Jazz Pharms., Inc. v. Avadel CNS Pharms.
- Briefly: Behind the Veil of Judicial Recusal
- Pharmacyclics LLC v. Alvogen, Inc.
- Novartis Pharms Corp. v. Crystal Pharm. (Suzhou) Co., Ltd.
- Allergan USA, Inc. v. Sun Pharm. Indus. Ltd.
- AstraZeneca AB v. Mylan Pharms. Inc.
- Horizon Medicines LLC v. Apotex Inc.
- November 1, 2022Briefly: 'Extraordinary Circumstances' For Relief from Judgment
- Third QuarterANDA Approvals
- Third QuarterANDA Litigation Settlements
- Third QuarterGeneric Launches
- Third QuarterNew ANDA Cases
- Tolmar Therapeutics, Inc. v. Foresee Pharms. Co., Ltd.
- October 2022In No Uncertain Terms
- October 7, 2022The Perils of Piecemeal Invocation of Arbitration Rights
- September 2022Constituency Statutes: The Overlooked Predecessor to the ESG Movement
- September 27, 2022Briefly: 8th Circuit Introduces Quality Control Aid for Briefs
- In re Entresto (Sacubitril/Valsartan) Patent Litigation
- September 2022Greenwashing Litigation is Increasing
- September 2022Legal Strategies For ESG Initiatives
- Uber Company Systems Compromised by Widespread Cyber Hack
- US Averts Rail Workers Strike With Last-Minute Tentative Deal
- Bial-Portela & Ca. S.A. v. Alkem Labs. Ltd.
- Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
- Founder and Exec Chair John Foley Resigns From Struggling Peloton
- Patent Value: Scoring Patents Using Characteristics Of Patents In Litigation
- September 2022Update on Exactech Knee, Hip, and Ankle Implant Recall Lawsuit
- September 202215 Years Later: The I-35 Bridge Collapse and the Lessons Carried On
- ECB Goes Big on Rate Hike to Battle Eurozone Inflation
- Fed Primes Markets for 75bps Rate Hike As Inflation Fight Continues
- Juul Reaches Deal with States to Settle Teen Marketing Allegations for $438M
- September 2, 2022Trade Dress Through a Trial Lens: Six Strategy Tips For Litigants
